SASKATOON, March 26, 2018 /CNW/ - Bold Growth Inc. (Bold Growth) has officially broken ground on its 56,018 square-foot cultivationand processing facility on the outskirts of Saskatoon, SK.
The precisely designed facility strictly adheres to Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) guidelines. Focusing on
Bold Growth's two-storey facility is being constructed on 62 acres of land and will house three phases of development, including an extraction and processing lab.
Bold Growth expects to submit an evidence package to Health Canada in October 2018 demonstrating adherence to the AMCPR guidelines and readiness to begin cultivation in Phase 1 of the development.
About Bold Growth Inc.
Bold Growth is a late-stage applicant to become a Licensed Producer under Health Canada's ACMPR and has successfully passed the security clearance phase of the application in December 2017 and is currently in the review stage.
With construction underway, Bold Growth anticipates submitting an evidence package to Health Canada in October 2018 to receive a cultivation license and commence operations
"Our purpose-built facility is located on 62 acres of strategically selected property on the outskirts of Saskatoon, positioning us to effectively serve both the Prairie Provinces and broader Canadian market," said Andrew Condin, President of Bold Growth. "Once complete, our state-of-the-art facility will allow us to produce a high-yielding, premium product while maintaining low production costs."
Cautionary note regarding forward looking statements: Certain statements contained in this release may be considered "forward looking" and are prospective. These forward looking statements sometimes include words to the effect that we or our management believe or expect a stated condition or result. All estimates and all statements that describe our objectives, goals, or future plans are forward looking statements. Since forward looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated in such statements due to any number of factors, including, but not limited to, fluctuations in interest rates, political and economic conditions, industry competition and our ability to attract and retain key personnel. We do not undertake to review or update these forward looking statements.
SOURCE Bold Growth Inc
Subscribe to our Free Newsletters!
Take the quiz on Rabies and test your knowledge about this infection that can affect the brain ...
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...View All